Bloomage Biotechnology Corp Ltd
SSE:688363
Bloomage Biotechnology Corp Ltd
SSE:688363
Price:
42.83
CNY
1.98%
Market Closed
Market Cap:
¥20.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Bloomage Biotechnology Corp Ltd
SSE:688363
|
CN |
|
W
|
Woori Technology Investment Co Ltd
KOSDAQ:041190
|
KR |
|
La Francaise de l Energie SA
PAR:FDE
|
FR |
|
Northern Graphite Corp
XTSX:NGC
|
CA |
|
M
|
Muhibbah Engineering (M) Bhd
KLSE:MUHIBAH
|
MY |
|
H
|
Horisont Energi AS
OSE:HRGI
|
NO |
Multiples-Based Value
The
Multiples-Based Value for
Bloomage Biotechnology Corp Ltd (688363)
under the Base Case is
hidden
CNY.
Compared with the current market price of 42.83 CNY, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Bloomage Biotechnology Corp Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Bloomage Biotechnology Corp Ltd Competitors
Bloomage Biotechnology Corp Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Bloomage Biotechnology Corp Ltd
SSE:688363
|
20.5B CNY | 4.4 | 317 | 274.5 | 274.5 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
374.1B USD | 6.1 | 89.4 | 14.8 | 20.5 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.5B USD | 5.1 | 24.4 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
175.7B USD | 6 | 20.7 | 12.9 | 15.9 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.8B USD | 9.4 | 28.5 | 21.4 | 22.4 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82B USD | 5.7 | 18.2 | 13.7 | 15.6 | |
| NL |
|
argenx SE
XBRU:ARGX
|
41.5B EUR | 11.7 | 37.5 | 40.4 | 41.3 | |
| AU |
|
CSL Ltd
ASX:CSL
|
68.5B AUD | 3 | 33.2 | 11.2 | 14 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
